HEALTH AND PLANT PROTEIN GROUP LIMITED 
By
21 May 2014
Dear Shareholder
Buderim Ginger Limited (Company) today announced that it is undertaking a pro-rata renounceable entitlement offer to raise up to $10.35 million (before offer costs) (Entitlement Offer).
The Entitlement Offer provides eligible shareholders with the opportunity to subscribe for 1 new share for every 1 existing share held at 7pm (Sydney time) on Tuesday 27 May 2014 at an issue price of $0.50 per New Share.
This letter is to inform you that, unfortunately, you are not eligible to participate in the
Entitlement Offer. You are not required to do anything in response to this letter.
Shareholders who are eligible to participate in the Entitlement Offer (Eligible Shareholders)
are those persons who:
(a) are registered as a holder of ordinary Buderim Ginger shares as at 7pm (Sydney time) on Tuesday 27 May 2014 (Record Date);
(b) have a registered address on the Company's register of members in Australia and
New Zealand;
(c) are not in the United States and are not a U.S. Person and are not acting for the account or benefit of a US Person; and
(d) are eligible under all applicable securities laws to receive an offer under the
Entitlement Offer.
The Company has determined, pursuant to section 9A(3)(a) of the Corporations Act 2001 (Cth) and Listing Rule 7.7.1(a) of the ASX Listing Rules, that it would be unreasonable to make offers to shareholders in countries outside of Australia and New Zealand in connection with the Entitlement Offer.
The securities laws of many countries require the use of offer documents specific to that country or compliance with local laws for the Entitlement Offer to be made in those countries. Having regard to the number of retail shareholders in particular countries, the number and value of the Company's ordinary shares to which those shareholders would otherwise be entitled and the potential cost of compliance with local laws to make the Entitlement Offer in those countries, the Company has limited the countries in which the Entitlement Offer will be made.
Unfortunately, according to our records, you do not satisfy the eligibility criteria for an Eligible
Shareholder stated above.
Accordingly, in compliance with ASX Listing Rule 7.7.1(b), the Company wishes to advise you that it will not be extending the Entitlement Offer to you and you will not be able to subscribe for new shares under the Entitlement Offer.
As an ineligible shareholder you are not required to do anything in response to this letter.
The Company has appointed Shaw Stockbroking Limited (Nominee), to arrange for the sale of the entitlements which would have been granted to you under the Entitlement Offer.
The Company will issue the entitlements to the Nominee that would otherwise have been granted to you. The Nominee will not be subscribing for the New Shares but may dispose of the Entitlements in its absolute and sole discretion.
The Nominee will have the absolute discretion to determine the timing and the price at which the entitlements may be sold and the manner of any such sale.
Subject to it being economic to do so, the Nominee will transfer any sale proceeds (net of expenses) to the Company's share registry who will distribute the net sale proceeds (if any) to each of those ineligible shareholders for whose benefit the entitlements are sold in proportion to the ineligible shareholders' entitlement.
Please note that neither the Company nor the Nominee will be held liable for the sale of such entitlements at any particular price or the timing of such sale.
On behalf of the directors and management of the Company, we regret that you are not eligible to participate in the Entitlement Offer and thank you for your continued support.
Yours sincerely,
Steve Morrow
|
distributed by
|
